Jane Street’s Astrana Health ASTH Stock Holding History

Jane Street’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,300	Closed	-$318K	–	9923
2023 Q3	$318K	Buy	+10,300	New	+$355K	﹤0.01%	6981
2022 Q1	–	Sell	-7,300	Closed	-$536K	–	11143
2021 Q4	$536K	Buy	+7,300	New	+$600K	﹤0.01%	7126

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jane Street's ASTH Position: Q2 2026 in Review

Jane Street sold out of Astrana Health (ASTH) in Q2 2026, closing a stake of 32,868 shares — an estimated $1.18M sold.

Jane Street first reported a position in ASTH in Q3 2021 and held it in 16 quarters. The position peaked at $39M in Q3 2024. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

Jane Street reported no remaining Astrana Health position as of Q2 2026 after selling out during the quarter.
Jane Street sold 32,868 Astrana Health shares in Q2 2026, an estimated $1.18M.
Jane Street first reported a position in Astrana Health in Q3 2021 and held it in 16 quarters.
Jane Street's Astrana Health position peaked at $39M in Q3 2024.
209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.